Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Jury orders Bayer to pay $100 million over PCBs in Washington school
A Washington state jury on Tuesday said Bayer must pay $100 million to four people who say they were sickened by exposure to toxic chemicals known as PCBs made by the company's predecessor Monsanto that were used in light fixtures at a Seattle-area school,
Bayer Says It Was Told by Jury to Pay $100 Million Over Toxic Chemicals
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain damage and other injuries.
Bayer faces billions in payouts for half century-old toxic mess
Bayer is facing billions of dollars in exposure from a growing number of lawsuits over PCB products. Read more at straitstimes.com.
Bayer Hit With $100 Million Verdict Over School’s Toxic PCBs (2)
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain damage and other injuries.
6d
Cutting Middle Management: Bayer's Costly Experiment One Year Later
In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.
15h
Bayer Leverkusen edge Mainz 1-0 for seventh league win in a row
Champions Bayer Leverkusen battled past Mainz 05 with a 1-0 win coming courtesy of a superb Alex Grimaldo free kick on ...
13h
Bayer sees new drugs boosting return to growth in 2027, WSJ reports
Growth is on the horizon for German drug conglomerate Bayer (BAYRY), despite “falling sales of its blockbuster blood thinner Xarelto,”amid ...
12d
Bayer: Sell And Be Done With It
Bayer's projected earnings decline and litigation pressures affect its outlook. Find out why BAYRY stock might face ...
1d
on MSN
Bayer plant doch keine Pharma-Großdeals, Fokus Schuldenabbau
Mit Blick auf die Neuausrichtung der Medikamentenpipeline von Bayer hatte Pharma-Chef Stefan Oelrich im letzten Januar ...
FierceBiotech
2d
JPM25: Bayer moves allogeneic cell therapy into phase 3 Parkinson's trial
Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...
6d
Bayer says menopause drug succeeds in breast cancer study
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...
21h
on MSN
Bayer pharma chief sees no big acquisitions in near future
Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback